The server is under maintenance between 08:00 to 12:00 (GMT+08:00), and please visit later.
We apologize for any inconvenience caused
Login  | Sign Up  |  Oriprobe Inc. Feed
China/Asia On Demand
Journal Articles
Laws/Policies/Regulations
Companies/Products
Bookmark and Share
Development of H22 -Tumor-Bearing Mice in Different Treatment Stages
Author(s): 
Pages: 31-33
Year: Issue:  3
Journal: ACTA UNIVERSITATIS TRADITIONIS MEDICALIS SINENSIS PHARMACOLOGIAEQUE SHANGHAI

Keyword:  分期论治荷瘤小鼠肝癌生存期中医药疗法;
Abstract: 目的观察中医药分期论治对荷瘤小鼠的治疗作用及对生存期的影响.方法将昆明种小鼠除正常组外,接种H22瘤株,制备肝癌模型,并随机分为模型组、西药组、非阶段组和阶段组.西药组予喃氟啶(FT-207),非阶段组予自拟肿瘤基本方,阶段组根据不同治则予肿瘤分阶段处方.观察各组对荷瘤小鼠生长的影响.结果模型组小鼠生存期最短,阶段组生存期最长,而西药组与非阶段组生存期非常接近.结论荷瘤小鼠经不同治法分阶段治疗后其生存期呈现延长的趋势.
Related Articles
No related articles found